Hälsa & medicin
5.1
Drug Combination Shows Promise Against Rare Childhood Brain Cancer
Researchers found that combining two types of inhibitor drugs—PARP and WEE1 inhibitors—may effectively treat a aggressive form of medulloblastoma in laboratory tests. If validated in clinical trials, this could offer a new treatment option for a pediatric cancer with limited current therapies and significant market opportunity.
Originaltitel: Combination of PARP and WEE1 inhibitors <i>in vitro</i>: Potential for use in the treatment of SHH medulloblastoma